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Preface
Kidney Research and Clinical Practice (Kidney Res Clin 
Pract, KRCP) is the official full-text English journal that 
represents the Korean Society of Nephrology (KSN), the 
largest professional society in Korea. KRCP has been pub-
lished since 1982 and was initially published in Korean as 
the Korean Journal of Nephrology until 2012. To extend 
the scope of its readership globally, it was renamed KRCP 
and became an international, peer-reviewed journal pub-
lished in English; its subscribers include over 10,000 cur-
rent members and physicians and scientists from all over 
the world. KRCP has become an internationally recog-
nized journal listed in SCOPUS, as well as in the emerg-
ing sources citation index (ESCI) in 2016. Since January 
2012 [1], Professor Gheun-Ho Kim has been the Editor-
in-Chief of the journal. His dedication to KRCP has been 
a stepping stone for the advancement and international-
ization of Korean kidney disease research. On behalf of 
KSN members and KRCP Editorial Board Members, we 
would like to express our gratitude for his passion and 
hard work, as well as that of the previous editors. 
This journal has changed every 5 years, a renovation, 
with a new Editor-in-Chief and a new team of Deputy 
and Associate Editors. This issue introduces the future 
editorial members. I am deeply honored to be selected to 
be the new Editor-in-Chief of KRCP. 
Past
Since conversion to English in 2012, KRCP has pub-
lished various peer-reviewed academic papers in special-
ized nephrology fields quarterly both domestically and 
abroad. As a global kidney journal, numerous interna-
tional researchers have submitted manuscripts and had 
them accepted after blinded review by experts and pro-
fessional editing. KRCP publishes the latest knowledge 
on scientifically interesting topics related to nephrology. 
In addition, specialized topics emerging as public health 
concerns have been reported. In particular, pressing 
public health issues related to patient care have been 
presented to readers in a timely manner. For example, 
during the Middle East respiratory syndrome (MERS) 
outbreak in 2015, KRCP announced the MERS clinical 
practice guideline for hemodialysis (HD) facilities with 
the help of the Korean Society of Nephrology MERS-CoV 
Task Force Team [2]. Recently, the coronavirus disease 
2019 (COVID-19) pandemic has become a public health 
crisis with over 21.2 million people diagnosed with the 
virus and 761,000 attributed deaths as of August 16, 2020. 
HD patients are very difficult to isolate from potential 
sources of infection due to the nature of dialysis treat-
ment in a limited HD unit. COVID-19 clinical practice 
guidelines for HD facilities were developed by a joint 
committee comprised of members from the KSN, the Ko-
rean Society for Dialysis Therapy, and the Korea Disease 
Control and Prevention Agency. Korean clinical practice 
guidelines for preventing transmission of COVID-19 in 
HD facilities was also published in KRCP [3]. The current 
guidelines direct dialysis specialists and dialysis patients 
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to recommend prevention, protection, screening, and 
isolation against the transmission of COVID-19 dur-
ing this pandemic. Timely publishing of domestic and 
global health issues in KRCP expands opportunities to 
share academic knowledge and practical experience that 
will improve the care of patients both domestically and 
globally. An issue arising from natural disasters was also 
published in KRCP. Although the Korean Peninsula has 
been considered an earthquake-free zone, an earthquake 
suddenly occurred in the Gyeongju province, which was 
a major public health issue. In dialysis units, HD treat-
ment was suddenly interrupted due to power failure and 
the need to evacuate patients for safety reasons. In that 
special article in a 2019 issue of KRCP, experience of the 
dialysis unit during a natural disaster in Gyeongju was 
introduced, and a plan for addressing issues related to 
natural disasters such as earthquakes was developed [4]. 
As social issues can also be published in KRCP, recent 
legislation (“Act on Decisions on Life-Sustaining Treat-
ment for Patients in Hospice and Palliative Care or at 
the End of Life,” act no. 14013) on the suspension of life-
sustaining medical care was described, and HD as a life-
sustaining treatment at the end of life was discussed [5].
In addition, in cooperation with leading journals, we 
simultaneously published a section unifying and clarify-
ing the nomenclature for kidney function and diseases to 
effectively improve global communication [6,7]. More-
over, KRCP provided a venue for the shared consensus 
from joint academic meetings with the Korean Diabetes 
Association [8,9]. Through these processes, we believe 
that unresolved and undisclosed scientific problems in 
the field of nephrology, as well as issues across different 
fields, can be discussed, and through this, the academic 
level can be raised one step further.
Future
KRCP’s mission during the last 5 years had been to be-
come one of the leading journals worldwide on the topic 
of nephrology. These could be accomplished, in many 
ways, to standardize the journal format and publish the 
valuable manuscript given the interest of many global 
readers. In order to honor the tradition of KRCP and fur-
ther expand it in the future, there are several important 
steps. In order to expand our readership base, we would 
like to focus on several areas. First, we seek to publish 
KRCP bimonthly in the near future, instead of quarterly. 
In addition, we will streamline the publication process 
to speed the time of submission and publication as 
much as possible. At the same time, we will make efforts 
to invite various reviewers for objective and accurate 
scientific evaluation. There are amazing new technolo-
gies to perform the basic research to nephrology field 
and remarkable innovation to gather and handle in the 
numerous clinical data. By introducing state-of-the-art 
research, KRCP will become one of the best journals in 
the nephrology field. In addition, we will try to share our 
knowledge by soliciting many professional reviews from 
experts in the field.
We are deeply grateful to the previous editors and as-
sociate editors who devoted hard work and sacrifice to 
KRCP’s success. First, We wish to thank the previous 
incumbents of the Editorial Board, Prof. Gheun-Ho Kim 
as Editor-in-Chief, and Prof. Dae Ryong Cha, Prof. Duk-
Hee Kang, Prof. Shin-Wook Kang, Prof. Yon Su Kim, Prof. 
Cheol Whee Park, Prof. Won Kim, and Prof. Dong-Ryeol 
Ryu as Associate Editors for their devotion to KRCP. I also 
would like to thank all previous Editorial Board Members 
for their hard work. We are pleased to welcome the fol-
lowing new Editorial Board Members: nephrologists Prof. 
Kyung Don Yoo, Prof. Woo Yeong Park, Prof. So-Young 
Lee, Prof. Soon Hyo Kwon, Prof. Jong Hyun Jhee, Prof. Jin 
Joo Cha, and Prof. Seon Ha Baek. KRCP has also invited 
Prof. Heeyeon Cho to the Editorial Board as a pediatric 
nephrologist, Prof. Kyung Chul Moon as a kidney pathol-
ogist, and Hyunsun Lim, Ph.D. as a statistical editor. 
All of the editorial members appreciate the continued 
interest and advice from our KRCP readers and members 
of the KSN, and look forward to reviewing your future 
research submissions. As the KRCP Editorial Committee, 
we seek to establish KRCP as a journal of the highest cali-
ber in the nephrology field.
Greetings on behalf of the editorial board.
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